Tetraphenylphosphonium chloride induced MR-visible lipid accumulation in a malignant human breast cell line

International Journal of Cancer

Volumn 67, Issue 1, 1996, Pages 72-79

  Delikatny, Edward J ^a   Roman, Sandrine K ^a   Hancock, Rebecca ^a   Jeitner, Thomas M ^a,c   Lander, Catherine M ^a   Rideout, Darryl C ^b,d   Mountford, Carolyn E ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b SCRIPPS CLINIC   (United States)

^c ALBANY MEDICAL COLLEGE   (United States)

^d San Diego Regional Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCEROPHOSPHORYLCHOLINE; LYSINE; PHOSPHOLIPID; TETRAPHENYLPHOSPHONIUM;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; HUMAN; HUMAN CELL; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LIPID METABOLISM; MAGNETIC RESONANCE SPECTROSCOPY; ONIUM COMPOUNDS; ORGANOPHOSPHORUS COMPOUNDS;

EID: 0030018207     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960703)67:1<72::AID-IJC13>3.0.CO;2-E     Document Type: Article

References (30)

1. BLOOMM. and THEWALTJ.L., Time and distance scales of membrane domain organization. Mol. Membrane Biol., 12, 9-13 (1995).
2. 1H NMR spectra of a myeloma cell line correlates with the induced formation of cytoplasmic lipid droplets. Magn. Reson. Med., 29, 546-550 (1993).
3. 1H NMR. J. biol. Chem., 263, 11664-11674 (1988).
4. CHENL.B., Mitochondrial membrane potential in living cells. Ann. Rev. Cell Biol., 4, 155-181 (1988).
5. 31P nuclear magnetic resonance study. Cancer Res., 50, 552-557 (1990).
6. 2H-NMR. Biochim. biophys. Acta, 737, 117-171 (1983).
7. DAVISS., WEISS, M.J., WONG, J.R., LAMPIDIS, T.J. and CHEN, L.B., Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine-123 by human breast adenocarcinoma-derived MCF-7cells. J. biol. Chem., 260, 13844-13850 (1985).
8. DELIKATNYE.J., HULL, W.E. and MOUNTFORD, C.E., The effect of altering time domains and window functions in two-dimensional proton COSY spectra of biological specimens. J. Magn. Reson., 94, 563-573 (1991).
9. DELIKATNYE.J., LANDER, C.M., JEITNER, T.M., HANCOCK, R. and MOUNTFORD, C.E., Modulation of MR-visible mobile lipid levels by cell culture conditions and correlations with chemotactic response. Int. J. Cancer 65, 238-245 (1996).
10. DINGLEYA.J., KING, N.J.C. and KING, G.F., An NMR investigation of the changes in plasma membrane triglyceride and phospholipid precursors during the activation of T-lymphocytes. Biochemistry, 31, 9098-9106 (1992).
11. FREITASI., PONTIGGIA, P., BARNI, S., BERTONE, V., PARENTE, M., NOVARINA, A., ROVETA, G., GERZELI, G. and STOWARD, P., Histochemical probes for the detection of hypoxic tumour cells. Anticancer Res., 10, 613-622 (1990).
12. 1H MR spectra of tumour cells during cell growth and after drug treatment. Proc. Soc. Magn. Res., 2, 1368 (1994).
13. HERRH.W., HUFFMAN, J.L., HURYK, R., HESTON, W.D.W., MELAMED, M.R. and WHIMORE, W.F. JR., Anticarcinoma activity of rhodamine 123 against a murine renal adenocarcinoma. Cancer Res., 48, 2061-2063 (1988).
14. HOLMESK.T., DYNE, M., WILLIAMS, P.G., MAY, G.L., TRIPP, E., WRIGHT, L.C. and MOUNTFORD, C.E., Vinblastine sensitivity of leukaemic lymphoblasts modulated by serum lipid. FEBS Lett., 244, 103-107 (1989).
15. 1H MR spectroscopy. NMR Biomed., 7, 172-180 (1994a).
16. 31P NMR studies of cultured human tumour cells: influence of pH on phospholipid metabolite levels and the detection of CDP-choline. NMR Biomed., 3, 78-89 (1990).
17. 1H MRS of high grade astrocytomas: mobile lipid accumulation in necrotic tissue. NMR Biomed., 7, 149-155 (1994b).
18. LAMPIDIST.J., HASIN, Y., WEISS, M.J. and CHEN, L.B., Selective killing of carcinoma cells in vitro by lipophilic cationic compounds: a cellular basis. Biomed. Pharmacother., 39, 220-226 (1985).
19. LEANC.L., MACKINNON, W.B., DELIKATNY, E.J., WHITEHEAD, R.H. and MOUNTFORD, C.E., Cell-surface fucosylation and magnetic resonance spectroscopy characterization of human malignant colorectal cells. Biochemistry, 31, 11095-11105 (1992).
20. 1H magnetic resonance spectroscopy. Int. J. Cancer, 59, 248-261 (1994).
21. MACKINNONW.B., RUSSELL, P., MAY, G.L. and MOUNTFORD, C.E., Characterisation of human ovarian epithelial tumours (ex vivo) by proton magnetic resonance spectroscopy. Int. J. Gynaecol. Oncol., 5, 211-221 (1995).
22. MAYG.L., WRIGHT, L.C., HOLMES, K.T., WILLIAMS, P.G., SMITH, I.C.P., WRIGHT, P.E., Fox, R.M. and MOUNTFORD, C.E., Assignment of methylene proton resonances in NMR spectra of embryonic and transformed cells to plasma membrane triglyceride. J. biol. Chem., 261, 3048-3053 (1986).
23. PILATUSU., DAVIS, D., WEHRLE, J., VAN ZIJL, P.C.M. and GLICKSON, J., Diffusion-weighted NMR spectroscopy of perfused MCF-7 cells: uptake of phenyl acetate. Proc. Soc. Magn. Res. Med., 2, 76 (1994).
24. RIDEOUTD., BUSTAMANTE, A. and PATEL, J., Mechanism of inhibition of FaDu hypopharyngeal carcinoma cell growth by tetraphenylphosphonium chloride. Int. J. Cancer, 57, 247-253 (1994).
25. RIDEOUTD., CALOGEROPOULOU, T., JAWORSKI, J., DAGNINO, R. JR. and MCCARTHY, M.R., Phosphonium salts exhibiting selective anticarcinoma activity in vitro. Anti-Cancer Drug Design, 4, 265-280 (1989).
26. RIDEOUTD., CALOGEROPOULOU, T., JAWORSKI, J. and MCCARTHY, M., Synergism through direct covalent bonding between agents: a strategy for rational design of chemotherapeutic combinations. Biopolymers, 29, 247-262 (1990).
27. ROBBINSS.L., COTRAN, R.S. and KUMAR, V., Pathologic basis of disease (2nd ed.), W.B. Saunders, Philadelphia (1984).
28. Ross, B.D., CHENEVERT, T.L., KIM, B. and BEN-YOSEPH, O., Magnetic resonance imaging and spectroscopy: application to experimental neuro-oncology. Quart. Magn. Reson. Biol. Med., 1, 89-106 (1994).
29. SINGERS., NEURINGER, L.J., THILLY, W.G. and CHEN, L.B., Quantitative differential effects of rhodamine 123 on normal cells and human colon cancer cells by magnetic resonance spectroscopy. Cancer Res., 53, 5808-5814 (1993).
30. 1H NMR of acid extracts. Biochim. biophys. Acta, 1054, 181-197 (1990).